Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma

Takahiro Higuchi, Syoutoku Tagawa, Naohiro Yoshida, Tsutomu Araki, Taketsugu Tsuchiya, Koutarou Higashi, Junichi Taki, Seigo Kinuya, Kenichi Nakajima, Masatoshi Ikeda, Masanobu Namura, Norihisa Tonami

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Several studies have shown the benefit of fluorine-18 fluorodeoxy glucose (FDG) imaging in the differentiation of solitary pulmonary nodules. The majority of malignant tumor have a higher glucose metabolic rate as compared to benign lesions. However, there is a considerable variety in glucose metabolic rate that depends on the aggressiveness and histological subtype of the tumor. Technetium-99m sestamibi (MIBI) is another tumor imaging agent for SPECT. We present a case of bronchioloalveolar cell carcinoma with a false negative finding in FDG imaging and a positive finding in MIBI imaging. This case clearly indicates that the FDG uptake and MIBI uptake might provide different information regarding characteristics of lung cancer.

Original languageEnglish
Pages (from-to)499-501
Number of pages3
JournalAnnals of nuclear medicine
Volume17
Issue number6
DOIs
Publication statusPublished - Sep 2003
Externally publishedYes

Fingerprint

Bronchiolo-Alveolar Adenocarcinoma
Fluorine
Glucose
Solitary Pulmonary Nodule
Technetium Tc 99m Sestamibi
Neoplasms
Single-Photon Emission-Computed Tomography
Lung Neoplasms

Keywords

  • Bronchioloalveolar cell carcinoma
  • Fluorine-18 fluorodeoxy glucose
  • Lung cancer
  • Myocardial perfusion SPECT
  • Technetium-99m sestamibi

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma. / Higuchi, Takahiro; Tagawa, Syoutoku; Yoshida, Naohiro; Araki, Tsutomu; Tsuchiya, Taketsugu; Higashi, Koutarou; Taki, Junichi; Kinuya, Seigo; Nakajima, Kenichi; Ikeda, Masatoshi; Namura, Masanobu; Tonami, Norihisa.

In: Annals of nuclear medicine, Vol. 17, No. 6, 09.2003, p. 499-501.

Research output: Contribution to journalArticle

Higuchi, T, Tagawa, S, Yoshida, N, Araki, T, Tsuchiya, T, Higashi, K, Taki, J, Kinuya, S, Nakajima, K, Ikeda, M, Namura, M & Tonami, N 2003, 'Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma', Annals of nuclear medicine, vol. 17, no. 6, pp. 499-501. https://doi.org/10.1007/BF03006442
Higuchi, Takahiro ; Tagawa, Syoutoku ; Yoshida, Naohiro ; Araki, Tsutomu ; Tsuchiya, Taketsugu ; Higashi, Koutarou ; Taki, Junichi ; Kinuya, Seigo ; Nakajima, Kenichi ; Ikeda, Masatoshi ; Namura, Masanobu ; Tonami, Norihisa. / Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma. In: Annals of nuclear medicine. 2003 ; Vol. 17, No. 6. pp. 499-501.
@article{0d1eedbe570a4e4981e5435ec6ee4a09,
title = "Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma",
abstract = "Several studies have shown the benefit of fluorine-18 fluorodeoxy glucose (FDG) imaging in the differentiation of solitary pulmonary nodules. The majority of malignant tumor have a higher glucose metabolic rate as compared to benign lesions. However, there is a considerable variety in glucose metabolic rate that depends on the aggressiveness and histological subtype of the tumor. Technetium-99m sestamibi (MIBI) is another tumor imaging agent for SPECT. We present a case of bronchioloalveolar cell carcinoma with a false negative finding in FDG imaging and a positive finding in MIBI imaging. This case clearly indicates that the FDG uptake and MIBI uptake might provide different information regarding characteristics of lung cancer.",
keywords = "Bronchioloalveolar cell carcinoma, Fluorine-18 fluorodeoxy glucose, Lung cancer, Myocardial perfusion SPECT, Technetium-99m sestamibi",
author = "Takahiro Higuchi and Syoutoku Tagawa and Naohiro Yoshida and Tsutomu Araki and Taketsugu Tsuchiya and Koutarou Higashi and Junichi Taki and Seigo Kinuya and Kenichi Nakajima and Masatoshi Ikeda and Masanobu Namura and Norihisa Tonami",
year = "2003",
month = "9",
doi = "10.1007/BF03006442",
language = "English",
volume = "17",
pages = "499--501",
journal = "Annals of Nuclear Medicine",
issn = "0914-7187",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma

AU - Higuchi, Takahiro

AU - Tagawa, Syoutoku

AU - Yoshida, Naohiro

AU - Araki, Tsutomu

AU - Tsuchiya, Taketsugu

AU - Higashi, Koutarou

AU - Taki, Junichi

AU - Kinuya, Seigo

AU - Nakajima, Kenichi

AU - Ikeda, Masatoshi

AU - Namura, Masanobu

AU - Tonami, Norihisa

PY - 2003/9

Y1 - 2003/9

N2 - Several studies have shown the benefit of fluorine-18 fluorodeoxy glucose (FDG) imaging in the differentiation of solitary pulmonary nodules. The majority of malignant tumor have a higher glucose metabolic rate as compared to benign lesions. However, there is a considerable variety in glucose metabolic rate that depends on the aggressiveness and histological subtype of the tumor. Technetium-99m sestamibi (MIBI) is another tumor imaging agent for SPECT. We present a case of bronchioloalveolar cell carcinoma with a false negative finding in FDG imaging and a positive finding in MIBI imaging. This case clearly indicates that the FDG uptake and MIBI uptake might provide different information regarding characteristics of lung cancer.

AB - Several studies have shown the benefit of fluorine-18 fluorodeoxy glucose (FDG) imaging in the differentiation of solitary pulmonary nodules. The majority of malignant tumor have a higher glucose metabolic rate as compared to benign lesions. However, there is a considerable variety in glucose metabolic rate that depends on the aggressiveness and histological subtype of the tumor. Technetium-99m sestamibi (MIBI) is another tumor imaging agent for SPECT. We present a case of bronchioloalveolar cell carcinoma with a false negative finding in FDG imaging and a positive finding in MIBI imaging. This case clearly indicates that the FDG uptake and MIBI uptake might provide different information regarding characteristics of lung cancer.

KW - Bronchioloalveolar cell carcinoma

KW - Fluorine-18 fluorodeoxy glucose

KW - Lung cancer

KW - Myocardial perfusion SPECT

KW - Technetium-99m sestamibi

UR - http://www.scopus.com/inward/record.url?scp=12444342657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444342657&partnerID=8YFLogxK

U2 - 10.1007/BF03006442

DO - 10.1007/BF03006442

M3 - Article

C2 - 14575387

AN - SCOPUS:12444342657

VL - 17

SP - 499

EP - 501

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

SN - 0914-7187

IS - 6

ER -